Bremelanotide PT-141 (10mg)

Precision-tested peptide formulated for advanced research applications.

• PT-141 (Bremelanotide) is a synthetic peptide analog derived from the melanocortin family.
• Explored in laboratory settings for its potential role in melanocortin receptor activity and neuroendocrine signaling.
• Each batch independently verified by Vanguard Laboratory for identity and purity.

PT-141 (Bremelanotide) is a cyclic heptapeptide analog of alpha-MSH that acts through melanocortin receptor pathways. It has been examined in laboratory and clinical research for its influence on neuronal signaling and vascular mechanisms

Studies have explored PT-141’s interaction with MC3R and MC4R receptors, providing insight into its broader peptide activity and receptor-specific mechanisms

Regulatory Status: PT-141 is not FDA-approved for human or veterinary use. This compound is supplied strictly for laboratory research applications.